Overview

Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Characteristics of HHT120 in Healthy Subjects

Status:
Not yet recruiting
Trial end date:
2023-01-15
Target enrollment:
Participant gender:
Summary
This is a first in human clinical trial with HHT120. The purpose of this study is to characterize the safety, pharmacokinetic (PK) and Pharmacodynamic (PD) profile of single and multiple twice-daily doses of HHT120 in healthy Subjects and to assess the effects of food on the PK profile of single-dose of HHT120 in healthy Subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.